- Home
- RCUS vs CEPU Comparison
RCUS vs CEPU Comparison
Compare RCUS & CEPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCUS | CEPU |
|---|---|---|
| Founded | 2015 | 1989 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | RCUS | CEPU |
|---|---|---|
| Price | $26.12 | $14.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $30.27 | $17.50 |
| AVG Volume (30 Days) | ★ 999.3K | 372.4K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $247,000,000.00 | N/A |
| Revenue This Year | N/A | $10.11 |
| Revenue Next Year | $45.62 | N/A |
| P/E Ratio | ★ N/A | $12.24 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.06 | $7.43 |
| 52 Week High | $26.40 | $18.50 |
Technical Indicators
Market Signals| Indicator | RCUS | CEPU |
|---|---|---|
| Relative Strength Index (RSI) | 65.38 | 41.76 |
| Support Level | $19.62 | $14.84 |
| Resistance Level | N/A | $16.82 |
| Average True Range (ATR) | 1.56 | 0.66 |
| MACD | 0.30 | -0.15 |
| Stochastic Oscillator | 69.54 | 12.15 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.